442 related articles for article (PubMed ID: 18466939)
1. Loiasis: African eye worm.
Padgett JJ; Jacobsen KH
Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):983-9. PubMed ID: 18466939
[TBL] [Abstract][Full Text] [Related]
2. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
[TBL] [Abstract][Full Text] [Related]
3. Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg).
Kamgno J; Pion SD; Tejiokem MC; Twum-Danso NA; Thylefors B; Boussinesq M
Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):777-85. PubMed ID: 17531279
[TBL] [Abstract][Full Text] [Related]
4. Control of onchocerciasis.
Boatin BA; Richards FO
Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
[TBL] [Abstract][Full Text] [Related]
5. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
Kamgno J; Pion SD; Chesnais CB; Bakalar MH; D'Ambrosio MV; Mackenzie CD; Nana-Djeunga HC; Gounoue-Kamkumo R; Njitchouang GR; Nwane P; Tchatchueng-Mbouga JB; Wanji S; Stolk WA; Fletcher DA; Klion AD; Nutman TB; Boussinesq M
N Engl J Med; 2017 Nov; 377(21):2044-2052. PubMed ID: 29116890
[TBL] [Abstract][Full Text] [Related]
6. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
[TBL] [Abstract][Full Text] [Related]
7. First case of ivermectin-induced severe hepatitis.
Veit O; Beck B; Steuerwald M; Hatz C
Trans R Soc Trop Med Hyg; 2006 Aug; 100(8):795-7. PubMed ID: 16682062
[TBL] [Abstract][Full Text] [Related]
8. Integrated rapid mapping of onchocerciasis and loiasis in the Democratic Republic of Congo: impact on control strategies.
Tekle AH; Zoure H; Wanji S; Leak S; Noma M; Remme JH; Amazigo U
Acta Trop; 2011 Sep; 120 Suppl 1():S81-90. PubMed ID: 20525531
[TBL] [Abstract][Full Text] [Related]
9. Rapid assessment method for prevalence and intensity of Loa loa infection.
Takougang I; Meremikwu M; Wandji S; Yenshu EV; Aripko B; Lamlenn SB; Eka BL; Enyong P; Meli J; Kale O; Remme JH
Bull World Health Organ; 2002; 80(11):852-8. PubMed ID: 12481206
[TBL] [Abstract][Full Text] [Related]
10. [Cutaneous filariasis Loa Loa: 26 moroccan cases of importation].
El Haouri M; Erragragui Y; Sbai M; Alioua Z; Louzi ; El Mellouki W; Sedrati O
Ann Dermatol Venereol; 2001 Sep; 128(8-9):899-902. PubMed ID: 11590341
[TBL] [Abstract][Full Text] [Related]
11. Loa loa vectors Chrysops spp.: perspectives on research, distribution, bionomics, and implications for elimination of lymphatic filariasis and onchocerciasis.
Kelly-Hope L; Paulo R; Thomas B; Brito M; Unnasch TR; Molyneux D
Parasit Vectors; 2017 Apr; 10(1):172. PubMed ID: 28381279
[TBL] [Abstract][Full Text] [Related]
12. Adverse reactions from community directed treatment with ivermectin (CDTI) for onchocerciasis and loiasis in Ondo State, Nigeria.
Otubanjo OA; Adeoye GO; Ibidapo CA; Akinsanya B; Okeke P; Atalabi T; Adejai ET; Braide E
Rev Biol Trop; 2008 Dec; 56(4):1635-43. PubMed ID: 19419072
[TBL] [Abstract][Full Text] [Related]
13. [Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
Ducorps M; Gardon-Wendel N; Ranque S; Ndong W; Boussinesq M; Gardon J; Schneider D; Chippaux JP
Bull Soc Pathol Exot; 1995; 88(3):105-12. PubMed ID: 8555762
[TBL] [Abstract][Full Text] [Related]
14. Meeting of the International Task Force for Disease Eradication, April 2011.
Wkly Epidemiol Rec; 2011 Aug; 86(32):341-51. PubMed ID: 21837843
[No Abstract] [Full Text] [Related]
15. Subconjunctival Loa Loa worm: case report.
Carbonez G; Van De Sompel W; Zeyen T
Bull Soc Belge Ophtalmol; 2002; (283):45-8. PubMed ID: 12058486
[TBL] [Abstract][Full Text] [Related]
16. Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
Ojurongbe O; Akindele AA; Adeleke MA; Oyedeji MO; Adedokun SA; Ojo JF; Akinleye CA; Bolaji OS; Adefioye OA; Adeyeba OA
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003633. PubMed ID: 25812086
[TBL] [Abstract][Full Text] [Related]
17. What are the mechanisms associated with post-ivermectin serious adverse events?
Boussinesq M; Kamgno J; Pion SD; Gardon J
Trends Parasitol; 2006 Jun; 22(6):244-6. PubMed ID: 16632406
[No Abstract] [Full Text] [Related]
18. Encephalopathy after ivermectin treatment in a patient infected with Loa loa and Plasmodium spp.
Kamgno J; Boussinesq M; Labrousse F; Nkegoum B; Thylefors BI; Mackenzie CD
Am J Trop Med Hyg; 2008 Apr; 78(4):546-51. PubMed ID: 18385346
[TBL] [Abstract][Full Text] [Related]
19. Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon.
Boussinesq M; Gardon J; Kamgno J; Pion SD; Gardon-Wendel N; Chippaux JP
Ann Trop Med Parasitol; 2001 Jul; 95(5):495-507. PubMed ID: 11487371
[TBL] [Abstract][Full Text] [Related]
20. Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa.
Thomson MC; Obsomer V; Dunne M; Connor SJ; Molyneux DH
Lancet; 2000 Sep; 356(9235):1077-8. PubMed ID: 11009145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
